“Growing Adoption of Bioinformatics in Precision Medicine and Drug Discovery”
- The increasing demand for personalized medicine is driving the integration of bioinformatics in genomic research, drug discovery, and biomarker identification to develop targeted therapies
- Pharmaceutical and biotech companies are leveraging bioinformatics-driven AI and machine learning tools to accelerate drug development, improve disease diagnosis, and enhance treatment efficacy
- The rising focus on next-generation sequencing (NGS) technologies and genomic data analysis is fueling investments in cloud-based bioinformatics platforms for scalable and efficient data processing
For instance,
- In March 2024, Illumina, Inc. partnered with AstraZeneca to enhance AI-based genomic interpretation tools for accelerating therapeutic target discovery
- In January 2024, Thermo Fisher Scientific launched a new bioinformatics-powered drug discovery platform, enabling faster and more precise pharmaceutical research
- In September 2023, BGI announced advancements in AI-driven genomic sequencing, improving the accuracy and speed of bioinformatics analysis for personalized medicine
- As the healthcare and pharmaceutical industries continue to embrace data-driven research, bioinformatics will remain pivotal in genomic medicine, drug innovation, and precision healthcare solutions, ensuring long-term industry growth
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Knowledge Management Tools and Bioinformatics Software and Services), Sector (Medical Biotechnology, Academics, Animal Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Others), Application (Genomics & Drug Development, Proteomics, Evolutionary Studies, Agricultural Studies, Veterinary Science, Metabolomics, Transcriptomics, and Others), Purchase Mode (Group Purchase and Individual Purchase), Method (Genomics and Proteomics) End-User, (Research and Academic Institutes, Clinical Research Organization, Biotech and Pharmaceutical Companies, Research Laboratories, Hospital, and Others) - Industry Trends and Forecast to 2032
.
The Global Bioinformatics Market size was valued at USD 14.27 USD Billion in 2024.
The Global Bioinformatics Market is projected to grow at a CAGR of 18.9% during the forecast period of 2025 to 2032.
The major players operating in the market include Thermo Fisher Scientific Inc., Illumina Inc., Agilent Technologies Inc., QIAGEN, SOPHiA GENETICS.
The market report covers data from the North America.
